GO:0006228 UTP biosynthetic process: Pyrimidine Nucleotide Synthesis, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006228 (UTP biosynthetic process) describes the biological process by which cells produce uridine-5'-triphosphate (UTP), the universal pyrimidine nucleotide used for RNA synthesis and as an activated precursor for UDP-sugars and CTP.
• UTP is synthesized through de novo pyrimidine biosynthesis and salvage pathways, with the final step often catalyzed by UTP synthase (CTPS1/CTPS2) or UDP-specific kinases.
• UTP biosynthesis is tightly coupled to mitochondrial pyruvate oxidation and de novo lipogenesis, linking nucleotide metabolism to central carbon metabolism.
• Dysregulation of UTP biosynthesis contributes to cancer, immune evasion, and metabolic disorders, making it a target for therapeutic intervention.
• Key enzymes include CAD, DHODH, UMPS, CTPS1, CTPS2, and UPRT, which are regulated by feedback inhibition and allosteric effectors.
• CRISPR knockout, point mutation, and overexpression models are essential to dissect the causal roles of UTP biosynthetic genes in disease.
Description
Uridine-5'-triphosphate (UTP) is a fundamental pyrimidine nucleotide that serves as a substrate for RNA synthesis and as a precursor for UDP-sugars, CTP, and other metabolites. The biological process GO:0006228, UTP biosynthetic process, encompasses the biochemical reactions that generate UTP from simpler precursors, including de novo synthesis from glutamine, ATP, and bicarbonate, as well as salvage pathways. This process is essential for cell proliferation, differentiation, and metabolic homeostasis, and its dysregulation is implicated in cancer, immune dysfunction, and developmental disorders. Researchers study UTP biosynthesis to understand how nucleotide availability influences gene expression, signaling, and metabolic reprogramming. The pathway intersects with mitochondrial metabolism, as pyrimidine synthesis supports pyruvate oxidation and lipogenesis. Moreover, purinergic signaling and epithelial transport are modulated by extracellular nucleotides like UTP, highlighting its broader physiological roles. Understanding UTP biosynthetic process is therefore critical for targeting metabolic vulnerabilities in disease.
UTP biosynthetic process At A Glance
| GO ID | GO:0006228 |
|---|---|
| GO term | UTP biosynthetic process |
| Ontology | biological_process |
| Synonym | None listed in QuickGO |
| Major function | Production of UTP for RNA synthesis, CTP formation, and UDP-sugar generation |
| Key enzymes | CAD, DHODH, UMPS, CTPS1, CTPS2, UPRT, NME1/2 |
| Pathways | De novo pyrimidine biosynthesis, salvage pathway |
| Cellular location | Cytosol, mitochondria (DHODH), nucleus (CTPS filaments) |
| Related diseases | Cancer, metabolic disorders, immune dysfunction |
What Is GO:0006228?
GO:0006228 (UTP biosynthetic process) is defined as the chemical reactions and pathways resulting in the formation of UTP, a pyrimidine ribonucleoside triphosphate. This process includes both de novo synthesis from small molecules and salvage of uridine or uracil. It is a child of pyrimidine nucleotide biosynthetic process and is essential for RNA synthesis and nucleotide sugar metabolism.
Why Is UTP biosynthetic process Important in Cell Biology?
UTP biosynthetic process is vital because UTP is not only a building block for RNA but also a key energy carrier and signaling molecule. Its synthesis is tightly linked to mitochondrial function and lipogenesis, and its dysregulation can drive cancer cell proliferation and immune evasion. Understanding this process provides insights into metabolic reprogramming and offers targets for therapeutic intervention.
• UTP is required for RNA synthesis and cell proliferation.
• UTP biosynthesis supports mitochondrial pyruvate oxidation and de novo lipogenesis.
• Dysregulation of UTP synthesis contributes to cancer and immune intractability.
• UTP serves as a precursor for CTP and UDP-sugars, impacting glycosylation and signaling.
• Extracellular UTP regulates purinergic signaling and epithelial transport.
• Enzymes in UTP biosynthesis are potential drug targets for cancer and viral infections.
• UTP biosynthesis is essential for perinatal galactose metabolism.
• Redox modulation of UDP-glucose pyrophosphorylase affects UTP utilization in plants.
• One-pot multienzyme synthesis of β-glycosides uses UTP-dependent enzymes.
• UTP biosynthetic pathways are conserved from bacteria to humans, enabling model organism studies.
What Happens During UTP biosynthetic process?
De Novo Pyrimidine Biosynthesis
In simple terms: The cell builds UTP from scratch using simple molecules like glutamine and bicarbonate.
De novo UTP synthesis begins with the formation of carbamoyl phosphate from glutamine, ATP, and bicarbonate by CAD (carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase). This is followed by a series of enzymatic steps including dihydroorotate dehydrogenase (DHODH) in mitochondria, and uridine monophosphate synthase (UMPS) to produce UMP. UMP is then phosphorylated to UDP and UTP by nucleoside diphosphate kinases (NME1/2) and UTP synthase (CTPS1/CTPS2).
Salvage Pathway
In simple terms: The cell recycles uridine or uracil from degraded RNA to make UTP.
The salvage pathway converts uridine to UMP via uridine kinase (UCK1/2) or uracil to UMP via uracil phosphoribosyltransferase (UPRT). UMP is then phosphorylated to UTP. This pathway is crucial for maintaining nucleotide pools under stress and is often upregulated in cancer cells.
Mitochondrial Connection
In simple terms: UTP synthesis is linked to mitochondrial energy production.
DHODH, a key enzyme in de novo pyrimidine synthesis, is located on the inner mitochondrial membrane and couples pyrimidine synthesis to the electron transport chain. Pyrimidines maintain mitochondrial pyruvate oxidation to support de novo lipogenesis, highlighting a metabolic axis.
Regulation by Feedback Inhibition
In simple terms: The end product UTP blocks its own production to prevent excess.
UTP and CTP feedback inhibit CAD and CTPS, ensuring balanced nucleotide pools. Allosteric regulation by GTP and ATP also modulates enzyme activity.
Integration with Purinergic Signaling
In simple terms: UTP can be released from cells to signal to neighbors.
Extracellular UTP acts on purinergic receptors (P2Y2, P2Y4) to regulate epithelial transport and endothelial barrier function, linking UTP biosynthesis to intercellular communication.
Role in Glycosylation
In simple terms: UTP is used to make sugars for modifying proteins and lipids.
UTP is a substrate for UDP-glucose pyrophosphorylase (UGP2) to produce UDP-glucose, which is essential for glycosylation and glycogen synthesis. Redox modulation of UGP2 affects its activity. One-pot multienzyme synthesis of β-glycosides also utilizes UTP-dependent enzymes.
Key Genes Involved in GO:0006228 UTP biosynthetic process
The following genes encode enzymes and regulators directly involved in UTP biosynthetic process.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CAD | Multifunctional enzyme catalyzing first three steps of de novo pyrimidine synthesis | Target for cancer therapy; knockout causes pyrimidine auxotrophy |
| DHODH | Mitochondrial enzyme converting dihydroorotate to orotate | Inhibitor target in cancer and autoimmune diseases; links to respiration |
| UMPS | Bifunctional enzyme producing UMP from orotate | Mutations cause orotic aciduria; target for antimetabolites |
| CTPS1 | UTP synthase converting UTP to CTP | Essential for lymphocyte proliferation; immunodeficiency target |
| CTPS2 | UTP synthase isoform | Tissue-specific roles; potential drug target |
| UPRT | Uracil phosphoribosyltransferase in salvage pathway | Used in suicide gene therapy; bacterial homolog studied |
| UCK1 | Uridine kinase for salvage synthesis | Regulates uridine homeostasis |
| UCK2 | Uridine kinase isoform | Mitochondrial uridine salvage |
| NME1 | Nucleoside diphosphate kinase | Generates UTP from UDP; metastasis suppressor |
| NME2 | Nucleoside diphosphate kinase | Maintains nucleotide pools; transcription factor |
| NME3 | Nucleoside diphosphate kinase | Mitochondrial dynamics |
| NME4 | Nucleoside diphosphate kinase | Mitochondrial intermembrane space |
| PRPS1 | Phosphoribosyl pyrophosphate synthetase | Provides PRPP for salvage; mutations cause gout |
| PRPS2 | PRPP synthetase isoform | Overexpressed in cancer |
| UGP2 | UDP-glucose pyrophosphorylase | Utilizes UTP for UDP-glucose; redox regulated |
| GALT | Galactose-1-phosphate uridylyltransferase | Uses UTP for galactose metabolism; perinatal defects |
| GALK1 | Galactokinase | Phosphorylates galactose; linked to UTP pool |
| P2RY2 | P2Y2 purinergic receptor | Responds to extracellular UTP; regulates transport |
How Is UTP biosynthetic process Regulated?
UTP biosynthetic process is regulated at multiple levels. Feedback inhibition by UTP and CTP on CAD and CTPS controls flux through the de novo pathway. Allosteric activation by GTP and ATP modulates CTPS filament formation. Hormonal and growth factor signaling, including mTOR, can influence pyrimidine synthesis to meet proliferative demands. Mitochondrial function and redox state affect DHODH activity and UGP2. Additionally, purinergic signaling via extracellular UTP provides feedback on cellular nucleotide status.
UTP biosynthetic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CAD | Cancer proliferation | Knockout in cancer cell lines; xenograft |
| DHODH | Autoimmune diseases, cancer | Point mutation to disable catalytic activity; inhibitor studies |
| CTPS1 | Immunodeficiency | Knockout in T cells; patient-derived iPSCs |
| UMPS | Orotic aciduria | Knock-in of patient mutations in cell lines |
| UGP2 | Glycosylation disorders | Overexpression and redox modulation |
Cancer Metabolism
Many cancers upregulate de novo pyrimidine synthesis to support rapid proliferation. CAD, DHODH, and CTPS1 are overexpressed in various tumors, and their inhibition reduces tumor growth. Pyrimidines maintain mitochondrial pyruvate oxidation for lipogenesis, a metabolic vulnerability in cancer.
Immune Dysfunction
CTPS1 deficiency causes severe immunodeficiency due to impaired lymphocyte proliferation. UTP biosynthesis is critical for immune cell activation, and its dysregulation contributes to immune intractability in cancer.
Metabolic Disorders
Defects in galactose metabolism, which utilizes UTP, cause perinatal complications such as galactosemia. Altered UTP synthesis affects glycosylation and energy homeostasis.
Neurological and Developmental Disorders
Nucleotide metabolism defects, including UTP synthesis, are linked to neurodevelopmental abnormalities. PRPS1 mutations cause gout and neurological impairment due to altered purine/pyrimidine balance.
From UTP biosynthetic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is CAD essential for cancer cell proliferation? | CRISPR knockout of CAD in HeLa or MCF7 cells |
| Does DHODH mutation affect mitochondrial respiration? | Point mutation of DHODH at catalytic site; Seahorse assay |
| Can CTPS1 deficiency be rescued by CTP supplementation? | Knockout of CTPS1 in Jurkat cells; media supplementation |
| What is the role of UGP2 in glycosylation? | Knock-in of tagged UGP2; mass spectrometry |
| How does UTP biosynthesis affect immune activation? | Overexpression of CTPS1 in primary T cells; proliferation assays |
| Does UPRT mediate salvage in cancer? | Knockout of UPRT in colorectal cancer cells; 5-FU sensitivity |
How to Study the UTP biosynthetic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| LC-MS/MS | Nucleotide levels (UTP, CTP, UDP-sugars) | Quantify UTP pools in cells |
| 13C-glutamine tracing | Flux through de novo pyrimidine synthesis | Cancer metabolism studies |
| CRISPR knockout screen | Gene essentiality for UTP biosynthesis | Identify novel regulators |
| Ribo-seq | Translation efficiency of UTP enzymes | Stress response studies |
| Proteomics | Protein expression and modifications | Regulatory mechanism discovery |
| Live-cell imaging | CTPS filament formation | Real-time dynamics |
| Enzymatic assays | CTPS, CAD, DHODH activity | Drug screening |
| RNA-seq | Transcriptional changes in UTP pathway | Pathway profiling |
Metabolic Flux Analysis
Isotope tracing with 13C-glutamine or 15N-glutamine can quantify flux through de novo pyrimidine synthesis. This method measures UTP pool labeling and pathway activity.
CRISPR Screening
Genome-wide CRISPR knockout screens can identify genes essential for UTP biosynthesis under various conditions, such as nutrient deprivation or drug treatment.
Proteomics and Phosphoproteomics
Mass spectrometry-based proteomics can detect post-translational modifications on UTP biosynthetic enzymes, revealing regulatory mechanisms.
Live-Cell Imaging
Fluorescent biosensors for UTP or CTPS filaments enable real-time visualization of nucleotide dynamics and enzyme assembly in living cells.
How CRISPR Can Be Used to Study GO:0006228 UTP biosynthetic process
Knockout
CRISPR knockout of CAD, DHODH, or CTPS1 in cell lines abolishes UTP synthesis, causing growth arrest that can be rescued by exogenous uridine or UTP precursors. This validates gene essentiality.
Point Mutation
Introducing point mutations in catalytic residues of DHODH or CTPS1 allows separation of enzymatic activity from non-catalytic functions, such as mitochondrial localization or filament formation.
Knock-in
Knock-in of tagged versions (e.g., GFP, HA) of UTP biosynthetic enzymes enables live-cell imaging and proteomic analysis of protein interactions and localization.
Overexpression
Overexpression of CTPS1 or CAD via CRISPR activation or lentiviral vectors can model oncogenic addiction and identify metabolic vulnerabilities.
How EDITGENE Supports UTP biosynthetic process Research
Researchers studying UTP biosynthetic process-related genes often need to determine whether a candidate gene is causally involved in nucleotide metabolism, cell proliferation, or disease. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for UTP biosynthetic process research.
Frequently Asked Questions About UTP biosynthetic process
What is UTP biosynthetic process?
UTP biosynthetic process (GO:0006228) is the set of biochemical reactions that produce uridine-5'-triphosphate (UTP) from simpler precursors, including de novo synthesis and salvage pathways.
What genes are involved in UTP biosynthetic process?
Key genes include CAD, DHODH, UMPS, CTPS1, CTPS2, UPRT, UCK1, UCK2, NME1-4, and UGP2.
Why is UTP biosynthesis important for cancer?
Cancer cells often upregulate UTP synthesis to support rapid proliferation and lipogenesis, making it a therapeutic target.
How is UTP biosynthetic process regulated?
It is regulated by feedback inhibition from UTP and CTP, allosteric activation by GTP, and signaling pathways like mTOR.
What diseases are linked to UTP biosynthesis defects?
Defects can cause immunodeficiency, orotic aciduria, galactosemia, and metabolic disorders.
What methods study UTP biosynthesis?
LC-MS/MS, isotope tracing, CRISPR screens, and live-cell imaging are commonly used.
Can CRISPR knockout of CAD affect cell growth?
Yes, CAD knockout abolishes de novo pyrimidine synthesis, causing growth arrest that can be rescued by uridine.
What is the role of DHODH in UTP synthesis?
DHODH catalyzes the fourth step of de novo pyrimidine synthesis in mitochondria, linking UTP production to respiration.
How does UTP relate to purinergic signaling?
Extracellular UTP activates P2Y receptors to regulate epithelial transport and endothelial barrier function.
What is the connection between UTP and glycosylation?
UTP is a substrate for UDP-glucose pyrophosphorylase to produce UDP-glucose, essential for glycosylation.
Conclusion
UTP biosynthetic process (GO:0006228) is a central metabolic pathway that supplies UTP for RNA synthesis, CTP production, and glycosylation. Its tight regulation and integration with mitochondrial metabolism make it a critical node in cancer, immune function, and metabolic disorders. CRISPR-based models are invaluable for dissecting the causal roles of UTP biosynthetic genes and for developing targeted therapies.
References
- 1. Sahu U et al.. 2024. Pyrimidines maintain mitochondrial pyruvate oxidation to support de novo lipogenesis.. Science 383(6690):1484-1492 PMID: 38547260
- 2. Aslam M et al.. 2021. Purinergic Regulation of Endothelial Barrier Function.. Int J Mol Sci 22(3) PMID: 33530557
- 3. Hinshaw DC et al.. 2024. A Metabolic Axis of Immune Intractability.. Cancer Immunol Res 12(3):282-286 PMID: 38126910
- 4. Kliegman RM et al.. 1985. Perinatal galactose metabolism.. J Pediatr 107(6):831-41 PMID: 3906069
- 5. Bucheimer RE et al.. 2004. Purinergic regulation of epithelial transport.. J Physiol 555(Pt 2):311-21 PMID: 14694149
- 6. Meng XL et al.. 2025. Efficient One-Pot Multienzyme Synthesis of β-Glycosides.. J Agric Food Chem 73(43):27611-27621 PMID: 41115857
- 7. Ipata PL et al.. 2013. The functional logic of cytosolic 5'-nucleotidases.. Curr Med Chem 20(34):4205-16 PMID: 23992316
- 8. Decker D et al.. 2023. Exploring Redox Modulation of Plant UDP-Glucose Pyrophosphorylase.. Int J Mol Sci 24(10) PMID: 37240260
